» Articles » PMID: 15976449

A Novel Rho-mDia2-HDAC6 Pathway Controls Podosome Patterning Through Microtubule Acetylation in Osteoclasts

Overview
Journal J Cell Sci
Specialty Cell Biology
Date 2005 Jun 25
PMID 15976449
Citations 104
Authors
Affiliations
Soon will be listed here.
Abstract

Osteoclast maturation is accompanied by changes in podosome patterning, resulting in the formation of a peripheral belt, which requires an intact microtubule network. Here, we report that by inhibiting Rho, the podosome belt is maintained at the cell periphery despite depolymerisation of microtubules by nocodazole. Rho inhibition was correlated to the increase in microtubule stabilisation and microtubule acetylation. By microinjecting activated Rho or its activated effector mDia2 in osteoclasts, we found that the podosome belt was disrupted and the level of microtubule acetylation dramatically decreased. We further characterised the molecular mechanism responsible for microtubule deacetylation by co-immunoprecipitation experiments. We found that not only was mDia2 coprecipitating with the recently identified microtubule deacetylase HDAC6 but that it also activated the microtubule deacetylase activity of HDAC6 in an in vitro deacetylase assay. Finally, we found that during osteoclastogenesis, there is a correlation between the increase in microtubule acetylation and the podosome belt stabilisation and that if Rho is inhibited in the early stages of osteoclast differentiation, it accelerates both microtubule acetylation and podosome belt stabilisation. Altogether, our data reveal a pathway in which Rho interferes with the osteoclast maturation process by controlling the level of microtubule acetylation and actin organisation through mDIA2 and HDAC6.

Citing Articles

Regulation of HDAC6 Catalytic Activity in Cancer: The Role of Post-Translational Modifications and Protein-Protein Interactions.

Asaad L, Pepperrell B, McErlean E, Furlong F Int J Mol Sci. 2025; 26(3).

PMID: 39941046 PMC: 11818932. DOI: 10.3390/ijms26031274.


Unlocking the Epigenetic Symphony: Histone Acetylation Orchestration in Bone Remodeling and Diseases.

Cai J, Deng Y, Min Z, Li C, Zhao Z, Yi J Stem Cell Rev Rep. 2024; 21(2):291-303.

PMID: 39495465 DOI: 10.1007/s12015-024-10807-2.


In Vitro Cell Culture Model for Osteoclast Activation during Estrogen Withdrawal.

Gandhi N, Omer S, Harrison R Int J Mol Sci. 2024; 25(11).

PMID: 38892322 PMC: 11173070. DOI: 10.3390/ijms25116134.


Hem1 is essential for ruffled border formation in osteoclasts and efficient bone resorption.

Werbenko E, de Gorter D, Kleimann S, Beckmann D, Waltereit-Kracke V, Reinhardt J Sci Rep. 2024; 14(1):8109.

PMID: 38582757 PMC: 10998871. DOI: 10.1038/s41598-024-58110-x.


Bone resorption by osteoclasts involves fine tuning of RHOA activity by its microtubule-associated exchange factor GEF-H1.

Morel A, Douat C, Blangy A, Vives V Front Physiol. 2024; 15:1342024.

PMID: 38312316 PMC: 10834693. DOI: 10.3389/fphys.2024.1342024.